Smith & Nephew PLC (SN)

1,023.50 -1.50 (-0.15%)
Closed GBP Disclaimer

Smith & Nephew PLC Company Profile

Equity Type
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Contact Information
Hatters Lane Watford,WD18 8YE United Kingdom
44 1923 477 100
44 1923 477 101
Top Executives
Marc E. Owen 64 2017 Senior Independent Director
Angie Susan Risley 65 2017 Independent Non-Executive Director
Deepak S. Nath 50 2022 CEO & Director
Rupert Christopher Soames 64 2023 Independent Non-Executive Chairman
C. Richard K. Medlock 64 2020 Independent Non-Executive Director
Jo C. Hallas 54 2022 Independent Non-Executive Director
Katarzyna Mazur-Hofsaess 60 2020 Independent Non-Executive Director
Robert John White 61 2020 Independent Non-Executive Director
Changzheng Ma 62 2021 Independent Non-Executive Director
Jeremy Kim Maiden 63 2023 Independent Non-Executive Director
John Terence Rogers 55 2024 CFO & Executive Director
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.